TSHA logo

Taysha Gene Therapies, Inc. (TSHA) Net Income

Annual Net Income:

-$89.30M+$22.27M(+19.96%)
December 31, 2024

Summary

  • As of today, TSHA annual net profit is -$89.30 million, with the most recent change of +$22.27 million (+19.96%) on December 31, 2024.
  • During the last 3 years, TSHA annual net income has risen by +$85.22 million (+48.83%).
  • TSHA annual net income is now -7908.79% below its all-time high of -$1.11 million, reached on December 31, 2019.

Performance

TSHA Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTSHAincome statement metrics

Quarterly Net Income:

-$26.88M-$5.35M(-24.86%)
June 30, 2025

Summary

  • As of today, TSHA quarterly net profit is -$26.88 million, with the most recent change of -$5.35 million (-24.86%) on June 30, 2025.
  • Over the past year, TSHA quarterly net income has dropped by -$5.95 million (-28.45%).
  • TSHA quarterly net income is now -156.31% below its all-time high of $47.74 million, reached on December 31, 2023.

Performance

TSHA Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTSHAincome statement metrics

TTM Net Income:

-$92.72M-$5.95M(-6.86%)
June 30, 2025

Summary

  • As of today, TSHA TTM net profit is -$92.72 million, with the most recent change of -$5.95 million (-6.86%) on June 30, 2025.
  • Over the past year, TSHA TTM net income has increased by +$21.61 million (+18.90%).
  • TSHA TTM net income is now -8215.70% below its all-time high of -$1.11 million, reached on December 1, 2019.

Performance

TSHA TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTSHAincome statement metrics

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

TSHA Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+20.0%-28.4%+18.9%
3Y3 Years+48.8%+21.1%+50.1%
5Y5 Years-7908.8%--329.5%

TSHA Net Income Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+48.8%-156.3%+77.0%-307.2%+56.9%
5Y5-Year-7908.8%+48.8%-156.3%+77.0%-329.5%+56.9%
All-TimeAll-Time-7908.8%+48.8%-156.3%+77.0%-8215.7%+56.9%

TSHA Net Income History

DateAnnualQuarterlyTTM
Jun 2025
-
-$26.88M(-24.9%)
-$92.72M(-6.9%)
Mar 2025
-
-$21.53M(-14.6%)
-$86.77M(+2.8%)
Dec 2024
-$89.30M(+20.0%)
-$18.79M(+26.4%)
-$89.30M(-292.1%)
Sep 2024
-
-$25.52M(-22.0%)
-$22.77M(+80.1%)
Jun 2024
-
-$20.93M(+13.0%)
-$114.33M(+3.1%)
Mar 2024
-
-$24.06M(-150.4%)
-$118.00M(-5.8%)
Dec 2023
-$111.57M(+32.8%)
$47.74M(+140.8%)
-$111.57M(+48.1%)
Sep 2023
-
-$117.09M(-376.0%)
-$215.03M(-72.8%)
Jun 2023
-
-$24.60M(-39.6%)
-$124.47M(+7.1%)
Mar 2023
-
-$17.62M(+68.4%)
-$133.96M(+19.6%)
Dec 2022
-$166.01M
-$55.72M(-110.1%)
-$166.66M(-3.3%)
Sep 2022
-
-$26.53M(+22.2%)
-$161.32M(+13.3%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$34.09M(+32.2%)
-$185.98M(+3.5%)
Mar 2022
-
-$50.32M(+0.1%)
-$192.82M(-10.5%)
Dec 2021
-$174.52M(-190.8%)
-$50.39M(+1.6%)
-$174.52M(-22.5%)
Sep 2021
-
-$51.19M(-25.1%)
-$142.46M(-34.0%)
Jun 2021
-
-$40.93M(-27.8%)
-$106.31M(-62.6%)
Mar 2021
-
-$32.02M(-74.8%)
-$65.38M(-68.6%)
Dec 2020
-$60.01M(-5282.2%)
-
-
Dec 2020
-
-$18.32M(-21.8%)
-$38.79M(-79.7%)
Sep 2020
-
-$15.04M(-177.0%)
-$21.59M(-229.8%)
Mar 2020
-
-$5.43M(-387.1%)
-$6.55M(-487.1%)
Dec 2019
-$1.11M
-
-
Dec 2019
-
-$1.11M
-$1.11M

FAQ

  • What is Taysha Gene Therapies, Inc. annual net profit?
  • What is the all-time high annual net income for Taysha Gene Therapies, Inc.?
  • What is Taysha Gene Therapies, Inc. annual net income year-on-year change?
  • What is Taysha Gene Therapies, Inc. quarterly net profit?
  • What is the all-time high quarterly net income for Taysha Gene Therapies, Inc.?
  • What is Taysha Gene Therapies, Inc. quarterly net income year-on-year change?
  • What is Taysha Gene Therapies, Inc. TTM net profit?
  • What is the all-time high TTM net income for Taysha Gene Therapies, Inc.?
  • What is Taysha Gene Therapies, Inc. TTM net income year-on-year change?

What is Taysha Gene Therapies, Inc. annual net profit?

The current annual net income of TSHA is -$89.30M

What is the all-time high annual net income for Taysha Gene Therapies, Inc.?

Taysha Gene Therapies, Inc. all-time high annual net profit is -$1.11M

What is Taysha Gene Therapies, Inc. annual net income year-on-year change?

Over the past year, TSHA annual net profit has changed by +$22.27M (+19.96%)

What is Taysha Gene Therapies, Inc. quarterly net profit?

The current quarterly net income of TSHA is -$26.88M

What is the all-time high quarterly net income for Taysha Gene Therapies, Inc.?

Taysha Gene Therapies, Inc. all-time high quarterly net profit is $47.74M

What is Taysha Gene Therapies, Inc. quarterly net income year-on-year change?

Over the past year, TSHA quarterly net profit has changed by -$5.95M (-28.45%)

What is Taysha Gene Therapies, Inc. TTM net profit?

The current TTM net income of TSHA is -$92.72M

What is the all-time high TTM net income for Taysha Gene Therapies, Inc.?

Taysha Gene Therapies, Inc. all-time high TTM net profit is -$1.11M

What is Taysha Gene Therapies, Inc. TTM net income year-on-year change?

Over the past year, TSHA TTM net profit has changed by +$21.61M (+18.90%)
On this page